CVS Health’s second quarter results surpassed Wall Street’s expectations, with management attributing the outperformance ...

Diversified healthcare company CVS Health (NYSE:CVS) in Q2 CY2025, with sales up 8.4% year on year to $98.92 billion. Its non ...

CVS Health reported an impressive adjusted operating income of $3.8 billion and an adjusted EPS of $1.81. The company has also increased its full-year 2025 adjusted EPS guidance to a range of $6.30 to ...

Investors responded with optimism following CVS Health’s CVS second-quarter 2025 earnings release last week, buoyed by better ...